Gerlach M - Search Results

1

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

Gerlach M, Riederer P, Przuntek H, Youdim MB. Gerlach M, et al. Eur J Pharmacol. 1991 Dec 12;208(4):273-86. doi: 10.1016/0922-4106(91)90073-q. Eur J Pharmacol. 1991. PMID: 1815982 Review.

2

The molecular pharmacology of L-deprenyl.

Gerlach M, Riederer P, Youdim MB. Gerlach M, et al. Eur J Pharmacol. 1992 Jun 5;226(2):97-108. doi: 10.1016/0922-4106(92)90170-z. Eur J Pharmacol. 1992. PMID: 1639115 Review.

3

Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?

Russ H, Mihatsch W, Gerlach M, Riederer P, Przuntek H. Russ H, et al. Among authors: gerlach m. Neurosci Lett. 1991 Feb 11;123(1):115-8. doi: 10.1016/0304-3940(91)90171-o. Neurosci Lett. 1991. PMID: 1712088

4

Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations.

Mihatsch W, Russ H, Gerlach M, Riederer P, Przuntek H. Mihatsch W, et al. Among authors: gerlach m. J Neural Transm Park Dis Dement Sect. 1991;3(1):73-8. doi: 10.1007/BF02251138. J Neural Transm Park Dis Dement Sect. 1991. PMID: 1905937

5

(-)-Deprenyl treatment of patients with Parkinson's disease does not affect erythrocyte catechol-O-methyl transferase activity.

Russ H, Gerlach M, Dettner O, Kuhn W, Przuntek H. Russ H, et al. Among authors: gerlach m. J Neural Transm Park Dis Dement Sect. 1991;3(3):215-23. doi: 10.1007/BF02259539. J Neural Transm Park Dis Dement Sect. 1991. PMID: 1958292

6

[Mercaptopurine and silylated mercaptopurine the treatment of experimental allergic encephalomyelitis].

Vohl ML, Westarp ME, Wekerle H, Gerlach M, Jutzi P, Przuntek H. Vohl ML, et al. Among authors: gerlach m. Arzneimittelforschung. 1990 Jan;40(1):80-4. Arzneimittelforschung. 1990. PMID: 2340004 German.

7

4,4-Diphenylpiperidine derivates and their sila analogues. A comparative study of their interaction with neural receptor biding sites and synaptosomal monoamine uptake.

Stasch JP, Russ H, Schacht U, Witteler M, Neuser D, Gerlach M, Leven M, Kuhn W, Jutzi P, Przuntek H. Stasch JP, et al. Among authors: gerlach m. Arzneimittelforschung. 1988 Aug;38(8):1075-8. Arzneimittelforschung. 1988. PMID: 2848535

8

Pharmacokinetic studies with sustained-release formulations of levodopa in healthy volunteers.

Gerlach M, Gebhardt B, Kuhn W, Przuntek H. Gerlach M, et al. J Neural Transm Suppl. 1988;27:211-8. doi: 10.1007/978-3-7091-8954-2_18. J Neural Transm Suppl. 1988. PMID: 3165436 Clinical Trial.

9

The effect of silyl substituted methotrexate in the treatment of experimental allergic encephalomyelitis in rats mediated by T-line cells.

Przuntek H, Westarp ME, Vohl ML, Gerlach M, Jutzi P, Wekerle H. Przuntek H, et al. Among authors: gerlach m. Neuropharmacology. 1987 Feb-Mar;26(2-3):255-60. doi: 10.1016/0028-3908(87)90216-4. Neuropharmacology. 1987. PMID: 3495744

10

The interactions of 1-alkyl-4,4-diphenylpiperidines with opiate receptors.

Neuser D, Stasch JP, Witteler M, Kuhn W, Gerlach M, Jutzi P, Przuntek H. Neuser D, et al. Among authors: gerlach m. Eur J Pharmacol. 1983 Feb 18;87(2-3):315-8. doi: 10.1016/0014-2999(83)90344-8. Eur J Pharmacol. 1983. PMID: 6301858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters